While the above are not specific to Low Dose Naltrexone (LDN), these studies demonstrate the beneficial affect that Naltrexone may have on liver disease such as Hepatitis C. In smaller doses, LDN appears to both enhance the immune system (by increasing endorphin levels), as well as being an anti-inflammatory; this has been demonstrated in prior clinical studies with LDN and other immune diseases.